# NeuroCognitive Communicator: Safety Study

> **NCT03100110** · NA · UNKNOWN · sponsor: **Ottawa Hospital Research Institute** · enrollment: 2 (estimated)

## Conditions studied

- Motor Neuron Disease, Amyotrophic Lateral Sclerosis
- Tetraplegia

## Interventions

- **DEVICE:** NeuroCognitive Communicator

## Key facts

- **NCT ID:** NCT03100110
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-13
- **Primary completion:** 2024-04-15
- **Final completion:** 2024-04-15
- **Target enrollment:** 2 (ESTIMATED)
- **Last updated:** 2022-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03100110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03100110, "NeuroCognitive Communicator: Safety Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03100110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*